As of April 17, 2026, Pelthos Therapeutics's top three insider holders are Pharmaceuticals Inc Ligand (TenPercentOwner, 1.50Mn shares), Todd C Davis (Director, 1.50Mn shares), Knuettel Ii Francis (Ceo, Pres., Cfo, Treas Secty, 547.71K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Todd C Davis | - | 0 | 1,500,000 | 03 Jul, 2025 |
| Pharmaceuticals Inc Ligand | - | 1,500,000 | 0 | 02 Jul, 2025 |
| Knuettel Ii Francis | Ceo, Pres., Cfo, Treas Secty | 0 | 547,710 | 16 Sep, 2024 |
| Ezra M Friedberg | - | 0 | 520,719 | 23 Feb, 2024 |
| Knuettel Ii Francis | Ceo, Pres., Cfo Treas Secty | 515,510 | 0 | 02 Jul, 2024 |
| Richard Malamut | - | 0 | 91,565 | 16 Sep, 2024 |
| Ezra M Friedberg | - | 82,027 | 0 | 06 Apr, 2026 |
| Ezra M Friedberg | - | 0 | 40,000 | 03 Jul, 2025 |
| Ezra M Friedberg | - | 0 | 30,000 | 26 Nov, 2025 |
| Richard Malamut | - | 27,422 | 0 | 06 Apr, 2026 |
| Peter Greenleaf | - | 24,681 | 0 | 06 Apr, 2026 |
| Matthew Pauls | - | 15,150 | 0 | 06 Apr, 2026 |
| Andrew J. Einhorn | - | 12,000 | 0 | 29 Dec, 2025 |
| Knuettel Ii Francis | Chief Financial Officer | 0 | 10,000 | 03 Jul, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Apr, 2026 | Ezra M Friedberg | Common Stock | D | 293 | $20.51 | 82,292 | D | S |
| 02 Apr, 2026 | Richard Malamut | Common Stock | D | 310 | $20.51 | 27,702 | D | S |
| 02 Apr, 2026 | Peter Greenleaf | Common Stock | D | 420 | $20.52 | 25,058 | D | S |
| 02 Apr, 2026 | Matthew Pauls | Common Stock | D | 415 | $20.52 | 15,521 | D | S |
| 02 Apr, 2026 | Peter Greenleaf | Common Stock | D | 377 | $21.36 | 24,681 | D | S |
| 02 Apr, 2026 | Ezra M Friedberg | Common Stock | D | 265 | $21.36 | 82,027 | D | S |
| 02 Apr, 2026 | Richard Malamut | Common Stock | D | 280 | $21.36 | 27,422 | D | S |
| 02 Apr, 2026 | Matthew Pauls | Common Stock | D | 371 | $21.36 | 15,150 | D | S |
| 23 Dec, 2025 | Andrew J. Einhorn | Common Stock | A | 12,000 | - | 12,000 | D | A |
| 02 Jul, 2025 | Matthew Pauls | Common Stock | A | 8,493 | $0.00 | 8,493 | D | M |
| 02 Oct, 2025 | Matthew Pauls | Common Stock | A | 2,123 | $0.00 | 10,616 | D | M |
| 10 Dec, 2025 | Matthew Pauls | Common Stock | D | 9,542 | $0.00 | 1,074 | D | G |
| 02 Jul, 2025 | Matthew Pauls | Restricted Stock Units | D | 8,493 | $0.00 | 16,985 | D | M |
| 02 Oct, 2025 | Matthew Pauls | Restricted Stock Units | D | 2,123 | $0.00 | 14,862 | D | M |
| 25 Nov, 2025 | Ezra M Friedberg | Common Stock | D | 5,999 | $28.00 | 34,001 | I | S |
| 25 Nov, 2025 | Ezra M Friedberg | Common Stock | D | 2,000 | $28.14 | 32,001 | I | S |
| 25 Nov, 2025 | Ezra M Friedberg | Common Stock | D | 1 | $28.50 | 32,000 | I | S |
| 25 Nov, 2025 | Ezra M Friedberg | Common Stock | D | 2,000 | $28.01 | 30,000 | I | S |
| 02 Jul, 2025 | Scott M. Plesha | Restricted Stock Units | A | 83,678 | - | 83,678 | D | A |
| 02 Jul, 2025 | Scott M. Plesha | Stock Option | A | 255,000 | - | 255,000 | D | A |